National Association of Testing Authorities, Australia
Scope of Accreditation
The Alfred Hospital
Site
Cellular Therapy Unit – Malignant Haematology, Transplantation and Cell Therapy Services
Accreditation No.
15790
Site No.
17012
Date of Accreditation
19 Aug 2008
Contact
Mrs Ayse Mouminoglu P: +61 (03) 90768336
Availability
Services available to external clients
Supervision
HPS (Haemopoietic processing, storage)
Scope of Accreditation
Cellular Therapy Unit – Malignant Haematology, Transplantation and Cell Therapy Services
ISO 15189 (2022)
- This facility complies with the relevant National Pathology Accreditation Advisory Council (NPAAC) requirements.
Human Pathology
Service | Product | Determinant |
---|---|---|
Immunopathology - Procedures related to the collection, processing, storage and issue of human haemopoietic progenitor cellsAllogeneic collection and/or processing; Autologous collection and/or processing; Product received from 17137-18733 | Blood; Bone marrow; Haemopoietic progenitor cells | Processing; Storage (includes freezing/thawing) |
Cord blood | Processing; Storage (includes freezing/thawing) | |
Molecular genetics - DNA extraction | Blood | Sample assessment and identification; Viable DNA for sequencing and other molecular assays |
Molecular genetics - Genetic testing for chimerism and mosaic gene variants (cancer and somatic mosaicism) - Targeted panels for non-inherited (somatic) DNA/RNA changes | Blood; Bone marrow; Buccal swabs | Quantitation of donor and recipient bone marrow derived cells in a transplant recipient |
The only data displayed is that deemed relevant and necessary for the clear description of the activities and services covered by the scope of accreditation.
Grey text appearing in a SoA is additional freetext providing further refinement or information on the data in the preceding line entry.
Accreditation No.
15790
Site No.
17012
Print date
28 Nov 2024
END OF SCOPE